Hook & thesis
Vicor is not a generic semiconductor bet; it sells high-density, patented power conversion building blocks that solve a real bottleneck for AI servers and accelerators. The company reported Q1 2026 revenue of $113.0 million, gross margins at 55.2% and a backlog that jumped to $301 million - a combination you rarely see at this scale in power components. That backlog, plus planned capacity expansion, makes a tactical long reasonable on a mid-term time frame.
That said, Vicor trades at a premium: market cap sits near $15.09 billion and the stock changes hands around $331.15, implying a price-to-earnings multiple north of 110 and price-to-sales near 35. The trade here is not a value play - it is a risk-managed momentum/structural-growth idea. If AI infrastructure customers continue to convert backlog into production orders and capacity ramps on schedule, the shares have room to run in the next 45 trading days. If execution slips, the valuation will punish rapidly - so strict risk management is essential.
What Vicor does and why it matters
Vicor designs and manufactures modular power components and complete power systems used in high-performance computing, data centers and aerospace/defense. Their technology is tailored to deliver high power density and efficiency where standard power supplies fall short - an increasingly critical requirement for AI accelerators and next-generation servers that push thermal, electrical and space limits.
The reason the market cares: AI compute growth creates an acute, specialized demand for power distribution that generalist suppliers cannot always meet without losing efficiency or density. Vicor's patented approach and modular modules make it an attractive vendor for hyperscalers and OEMs designing dense GPU/AI racks. That explains the 70% sequential surge in backlog reported alongside Q1 2026 results and the company's public commentary about a second fab and added manufacturing equipment.
Recent financials and operational evidence
- Q1 2026 revenue: $113.0 million, +20.2% year-over-year.
- Q1 2026 gross margin: 55.2%.
- Net income Q1 2026: $20.7 million, or $0.44 per diluted share.
- Backlog: $301 million, up 70% sequentially (company disclosure).
- Free cash flow (trailing figure in reported metrics): $87.3 million.
- Balance sheet signals: Current ratio ~14.3, quick ratio ~12.03, cash per share indicated at $9.64 and no reported debt.
Those are solid operational metrics: growing revenue, very healthy margins for the sector and meaningful cash conversion. The backlog is the key fundamental that can justify higher near-term multiples if it converts to revenue quickly and gross margin and pricing are preserved.
Valuation framing
At a market capitalization of roughly $15.09 billion and an enterprise value of about $14.7 billion, the company trades at roughly 110x reported earnings and roughly 35x sales. Those multiples are elevated and reflect a market pricing in both continued rapid growth and durable high margins. For context:
| Metric | Reported |
|---|---|
| Market Cap | $15.09B |
| Price (recent) | $331.15 |
| P/E | ~110 |
| Price/Sales | ~35 |
| EV/EBITDA | ~122.7 |
Those multiples mean the stock requires continued acceleration in revenue and gross margin retention - not just one good quarter - to sustain upside. The market appears to be baking in both ongoing AI server adoption and material licensing/recurring revenue upside: public reporting suggests nearly $300 million in expected IP licensing through 2026, which, if realized, would materially support revenue and margins.
Catalysts to watch
- Quarterly guidance raises: Another revenue/guidance raise would validate backlog conversion and spur multiple expansion.
- Capacity expansion updates: Confirmation of the second fab timeline or equipment installs that materially increase throughput.
- Large hyperscaler orders becoming public or disclosed in SEC filings - these accelerate revenue visibility.
- IP licensing flow - material payments or lawsuits resolved in Vicor's favor would add non-linear revenue.
- Industry signals: rising orders across other AI-infrastructure suppliers, as seen in related names, can lift sentiment.
Trade plan (actionable)
Thesis: Buy on momentum backed by robust backlog and capacity expansion, with disciplined risk controls because valuation is stretched.
| Entry | Stop loss | Target | Horizon |
|---|---|---|---|
| $331.15 | $300.00 | $380.00 | Mid term (45 trading days) |
Rationale: Entering at $331.15 gets you close to the recent trade level and near the 20-day/10-day technical support cluster (10-day SMA ~$300.62, 20/50-day SMAs lower), while keeping distance from the 52-week high. A $300 stop limits downside if topline conversion stalls or a broader tech sell-off hits. The $380 target is achievable within ~45 trading days assuming continued guidance improvement, order flow confirmation and positive commentary during the next earnings or investor updates - it represents roughly a 15% upside from current levels and rewards the risk while recognising the elevated multiples.
The suggested horizon is mid term (45 trading days). That window gives time for manufacturing ramp signals, order announcements or another guidance cycle to play out without exposing the position to longer-term valuation compression if growth decelerates.
Technical & market-micro considerations
Momentum indicators are constructive: the 9-day EMA sits around $313.66 and the RSI around 60.7, suggesting room to run before overbought extremes. Average volume over recent periods is elevated (two-week average ~710k; 30-day ~739k) and the free float is relatively tight (~24.9 million shares), which can amplify moves on accelerating demand or headline-driven flows. Short interest data shows around 1.56 million shares short on the last reported settlement date, with days-to-cover under 2 - a short squeeze is possible but not the primary thesis.
Risks and counterarguments
- Valuation sensitivity: At ~110x earnings and 35x sales, any revenue slowdown or margin compression would likely trigger sharp downside.
- Execution risk on capacity: Building a second fab and scaling production has execution complexity and lead times; delays would impair near-term revenue conversion.
- Customer concentration: Dependence on hyperscalers and a few large OEMs means order timing is lumpy and subject to customer budget cycles.
- Competitive risk: Larger power suppliers could attempt to undercut on price or integration, or new architectures could reduce Vicor's addressable share.
- Insider selling and sentiment: Some insiders have sold into the rally; while institutional buying remains strong, insider selling can weigh on sentiment if it accelerates.
- Macro/market risk: A broad tech drawdown or recession could push multiples back to more conservative levels regardless of company execution.
Counterargument: The most persuasive case against this trade is valuation. If you believe Vicor's growth will revert to more normalized levels after a one-time hyperscaler procurement cycle, paying >100x earnings is too aggressive. In that scenario, waiting for a reset or buying on a significant pullback would be wiser. This is why the trade uses a firm stop and a mid-term horizon - the upside depends on tangible execution, not narrative alone.
What would change my mind
I will reduce conviction or exit the position if any of the following occur:
- Backlog updates or customer disclosures show material cancellations or a sharp sequential drop in convertible orders.
- Management delays or defers the second fab or equipment ramp and cannot provide a credible near-term throughput improvement plan.
- Gross margins unexpectedly compress by several hundred basis points due to pricing pressure or component cost inflation.
- Insider selling accelerates dramatically while institutional nets flip from accumulation to distribution.
Conclusion
Vicor is a targeted way to play AI infrastructure's insatiable appetite for power density. Strong Q1 operating metrics, a large and growing backlog and clear capacity plans support a tactical mid-term long. The trade is not without risk: valuation is elevated and execution must be flawless to justify current pricing. That makes a disciplined entry at $331.15 with a $300 stop and a $380 target over 45 trading days a practical way to participate while containing downside.
Key dates to watch: quarterly updates, capacity announcements and any large customer order disclosures likely to occur within the next two quarters.
Trade plan summary: Buy $331.15, stop $300.00, target $380.00, mid term (45 trading days). Tight risk control is essential because the market has already priced high expectations into the stock.